Taxus Pharmaceuticals Holdings Inc.

Common Stock SEC Reporting - Delinquent
Verified Company Profile 11/21/2017
Contact Info
  • 245-16 Horace Harding Expressway
  • Little Neck, NY 11362

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-K
CIK 0001622676
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5912 - Drugstores and Proprietary Stores
Incorporated In: NY, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jiayue Zhang CEO, CFO
Bin Zhou Securities Counsel
Company Directors
Jiayue Zhang Chairman
Service Providers
Accounting/Auditing Firm
Wei Wei & Co., LLP
133-10 39th Avenue
Flushing, NY, 11354
United States

Legal Counsel
Bernard & Yam, LLP
140-75 Ash Avenue
Second Floor
Queens, NY, 11355
United States

Investor Relations Firm
Not Available
TXSP Security Details
Share Structure
Market Value1 $257,540,632 a/o Dec 14, 2017
Authorized Shares 1,500,000,000 a/o Dec 01, 2017
Outstanding Shares 81,500,200 a/o Dec 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC 50,100 a/o Dec 01, 2017
Float Not Available
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders of Record 39 a/o Jul 08, 2015
Short Selling Data
Short Interest 0 (-100%)
Aug 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security